Matsushita S - Search Results

1

Generation of a replication-competent simian-human immunodeficiency virus, the neutralization sensitivity of which can be enhanced in the presence of a small-molecule CD4 mimic.

Otsuki H, Hishiki T, Miura T, Hashimoto C, Narumi T, Tamamura H, Yoshimura K, Matsushita S, Igarashi T. Otsuki H, et al. Among authors: matsushita s. J Gen Virol. 2013 Dec;94(Pt 12):2710-2716. doi: 10.1099/vir.0.055590-0. Epub 2013 Sep 11. J Gen Virol. 2013. PMID: 24026672

2

Reconstitution of spontaneous neutralizing antibody response against autologous human immunodeficiency virus during highly active antiretroviral therapy.

Kimura T, Yoshimura K, Nishihara K, Maeda Y, Matsumi S, Koito A, Matsushita S. Kimura T, et al. Among authors: matsushita s. J Infect Dis. 2002 Jan 1;185(1):53-60. doi: 10.1086/338099. Epub 2001 Dec 14. J Infect Dis. 2002. PMID: 11756981

3

Emergence of autologous neutralization-resistant variants from preexisting human immunodeficiency virus (HIV) quasi species during virus rebound in HIV type 1-infected patients undergoing highly active antiretroviral therapy.

Wang FX, Kimura T, Nishihara K, Yoshimura K, Koito A, Matsushita S. Wang FX, et al. Among authors: matsushita s. J Infect Dis. 2002 Mar 1;185(5):608-17. doi: 10.1086/339015. Epub 2002 Feb 14. J Infect Dis. 2002. PMID: 11865417

4

Ability of small animal cells to support the postintegration phase of human immunodeficiency virus type-1 replication.

Koito A, Shigekane H, Matsushita S. Koito A, et al. Among authors: matsushita s. Virology. 2003 Jan 5;305(1):181-91. doi: 10.1006/viro.2002.1755. Virology. 2003. PMID: 12504551 Free article.

5

Susceptibility of mink (Mustera vision)-derived cells to replication by human immunodeficiency virus type 1.

Koito A, Kameyama Y, Cheng-Mayer C, Matsushita S. Koito A, et al. Among authors: matsushita s. J Virol. 2003 May;77(9):5109-17. doi: 10.1128/jvi.77.9.5109-5117.2003. J Virol. 2003. PMID: 12692213 Free PMC article.

6

The impact of highly active antiretroviral therapy by the oral route on the CD8 subset in monkeys infected chronically with SHIV 89.6P.

Yoshimura K, Ido E, Akiyama H, Kimura T, Aoki M, Suzuki H, Mitsuya H, Hayami M, Matsushita S. Yoshimura K, et al. Among authors: matsushita s. J Virol Methods. 2003 Sep;112(1-2):121-8. doi: 10.1016/s0166-0934(03)00201-5. J Virol Methods. 2003. PMID: 12951220

7

Spontaneous recovery of hemoglobin and neutrophil levels in Japanese patients on a long-term Combivir containing regimen.

Matsushita S, Yoshimura K, Kimura T, Kamihira A, Takano M, Eto K, Shirasaka T, Mitsuya H, Oka S. Matsushita S, et al. J Clin Virol. 2005 Jul;33(3):188-93. doi: 10.1016/j.jcv.2004.11.002. Epub 2004 Dec 10. J Clin Virol. 2005. PMID: 15911439 Clinical Trial.

8

Sequential immunization with V3 peptides from primary human immunodeficiency virus type 1 produces cross-neutralizing antibodies against primary isolates with a matching narrow-neutralization sequence motif.

Eda Y, Takizawa M, Murakami T, Maeda H, Kimachi K, Yonemura H, Koyanagi S, Shiosaki K, Higuchi H, Makizumi K, Nakashima T, Osatomi K, Tokiyoshi S, Matsushita S, Yamamoto N, Honda M. Eda Y, et al. Among authors: matsushita s. J Virol. 2006 Jun;80(11):5552-62. doi: 10.1128/JVI.02094-05. J Virol. 2006. PMID: 16699036 Free PMC article.

9

Anti-V3 humanized antibody KD-247 effectively suppresses ex vivo generation of human immunodeficiency virus type 1 and affords sterile protection of monkeys against a heterologous simian/human immunodeficiency virus infection.

Eda Y, Murakami T, Ami Y, Nakasone T, Takizawa M, Someya K, Kaizu M, Izumi Y, Yoshino N, Matsushita S, Higuchi H, Matsui H, Shinohara K, Takeuchi H, Koyanagi Y, Yamamoto N, Honda M. Eda Y, et al. Among authors: matsushita s. J Virol. 2006 Jun;80(11):5563-70. doi: 10.1128/JVI.02095-05. J Virol. 2006. PMID: 16699037 Free PMC article.

Eda, M. Takizawa, T. Murakami, H. Maeda, K. Kimachi, H. Yonemura, S. Koyanagi, K. Shiosaki, H. Higuchi, K. Makizumi, T. Nakashima, K. Osatomi, S. Tokiyoshi, S. Matsushita, N. Yamamoto, and M. Honda, J. Virol. 80:5552-5562, 2006), we discuss our product …

Eda, M. Takizawa, T. Murakami, H. Maeda, K. Kimachi, H. Yonemura, S. Koyanagi, K. Shiosaki, H. Higuchi, K. Makizumi, T. Nakashima, K. …

10

Ex vivo neutralization of HIV-1 quasi-species by a broadly reactive humanized monoclonal antibody KD-247.

Matsushita S, Takahama S, Shibata J, Kimura T, Shiozaki K, Eda Y, Koito A, Murakami T, Yoshimura K. Matsushita S, et al. Hum Antibodies. 2005;14(3-4):81-8. Hum Antibodies. 2005. PMID: 16720978

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,263 results

Search Page